Randomized Study of Darbepoetin Alfa and Recombinant Human Erythropoietin for Treatment of Renal Anemia in Chronic Renal Failure Patients Receiving Peritoneal Dialysis

Darbepoetin alfa can be administered less frequently than recombinant human erythropoietin (r-HuEPO) for the treatment of anemia in chronic renal failure (CRF) patients. We aimed to confirm that darbepoetin alfa at a reduced dosing schedule can safely maintain a target hemoglobin level in CRF patien...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Wen-Yi Li, Tzong-Shinn Chu, Jenq-Wen Huang, Ming-Shiou Wu, Kwan-Dun Wu
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Elsevier 2008-11-01
Seri Bilgileri:	Journal of the Formosan Medical Association
Konular:	anemia chronic renal failure darbepoetin alfa erythropoietin peritoneal dialysis
Online Erişim:	http://www.sciencedirect.com/science/article/pii/S0929664608602004
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!